F · Healthcare

ONCOTHERAPY SCIENCE INC. (30O)

Biotechnology

ONCOTHERAPY SCIENCE INC. (30O) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 30O

P/E ratio

18.00

ONCOTHERAPY SCIENCE INC. (30O) — FAQ

What is 30O's P/E ratio?

The price-to-earnings (P/E) ratio for ONCOTHERAPY SCIENCE INC. (30O) is 18.00 (data as of 2026-03-24).

Does ONCOTHERAPY SCIENCE INC. pay a dividend?

Dividend yield is not available in the current snapshot for ONCOTHERAPY SCIENCE INC. (30O). Check the MyAverix Finance app for the latest dividend data.

What sector is ONCOTHERAPY SCIENCE INC. in?

ONCOTHERAPY SCIENCE INC. (30O) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 30O listed on?

30O is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)